Shares of aerospace and defense company Rocket Lab (NASDAQ:RKLB)
jumped 4.1% in the afternoon session after it got positive commentary from Wall Street, including a price target increase from Roth Capital. On Monday, Roth Capital raised its price target on the stock to $60 from $50, while maintaining a “Buy” rating. The analyst noted impressive progress toward the initial launch of the company's Neutron rocket and strong Q2 2025 results, which included record revenue and gross margin expansion. The firm's increased confidence in the Neutron program supports its bullish thesis for the stock. This optimistic sentiment is echoed across Wall Street, as other firms like Needham, Cantor Fitzgerald, and Keybanc also recently raised their price targets following the company's solid operational performance.
Unprofitable companies face headwinds as they struggle to keep operating expenses under control.
Some may be investing heavily, but the majority fail to convert spending into sustainable growth.
Retail investors buzzed about five stocks this week, from Sept. 1 to 5, on platforms like X and Reddit’s r/WallStreetBets, amid market volatility and enthusiasm for AI.
Rocket Lab stock is trading lower Wednesday. The decline follows a multi-day surge that was fueled by a series of positive announcements from the company.
Rocket Lab's recent relative strength comes after a false breakdown attempt near $40, and several key catalysts, including the opening of Neutron's launch pad.
Shares of aerospace and defense company Rocket Lab (NASDAQ:RKLB)
jumped 3.7% in the afternoon session after the stock's positive momentum continued as the company announced it will receive a $23.9 million award under the CHIPS and Science Act and is opening its new Neutron launch complex this week.
